The report focuses on the Remicade (infliximab) Drug market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Remicade (infliximab) Drug market.
Major Players in the Remicade (infliximab) Drug market are:
Hospira
Samsung Bioepsis
Epirus Biopharmaceuticals
Janssen
Celltrion Healthcare
On the basis of types, the Remicade (infliximab) Drug market is primarily split into:
Brands Drugs
Generic Drugs
On the basis of applications, the market covers:
Crohn's Disease
Pediatric Crohn's Disease
Ulcerative Colitis
Pediatric Ulcerative Colitis
Other
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Remicade (infliximab) Drug Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Remicade (infliximab) Drug Market Overview
1.1 Product Overview and Scope of Remicade (infliximab) Drug Market
1.2 Remicade (infliximab) Drug Market Segment by Type
1.2.1 Global Remicade (infliximab) Drug Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Remicade (infliximab) Drug Market Segment by Application
1.3.1 Remicade (infliximab) Drug Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Remicade (infliximab) Drug Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Remicade (infliximab) Drug (2017-2029)
1.5.1 Global Remicade (infliximab) Drug Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Remicade (infliximab) Drug Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Remicade (infliximab) Drug Industry
1.7 Impact of Carbon Neutrality on the Remicade (infliximab) Drug Industry
2 Remicade (infliximab) Drug Market Upstream and Downstream Analysis
2.1 Remicade (infliximab) Drug Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Remicade (infliximab) Drug Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Hospira
3.1.1 Hospira Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Remicade (infliximab) Drug Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Samsung Bioepsis
3.2.1 Samsung Bioepsis Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Remicade (infliximab) Drug Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Epirus Biopharmaceuticals
3.3.1 Epirus Biopharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Remicade (infliximab) Drug Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Janssen
3.4.1 Janssen Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Remicade (infliximab) Drug Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Celltrion Healthcare
3.5.1 Celltrion Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Remicade (infliximab) Drug Market Performance (2017-2022)
3.5.4 Business Overview
4 Global Remicade (infliximab) Drug Market Landscape by Player
4.1 Global Remicade (infliximab) Drug Sales and Share by Player (2017-2022)
4.2 Global Remicade (infliximab) Drug Revenue and Market Share by Player (2017-2022)
4.3 Global Remicade (infliximab) Drug Average Price by Player (2017-2022)
4.4 Global Remicade (infliximab) Drug Gross Margin by Player (2017-2022)
4.5 Remicade (infliximab) Drug Market Competitive Situation and Trends
4.5.1 Remicade (infliximab) Drug Market Concentration Rate
4.5.2 Remicade (infliximab) Drug Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Remicade (infliximab) Drug Sales, Revenue, Price Trend by Type
5.1 Global Remicade (infliximab) Drug Sales and Market Share by Type (2017-2022)
5.2 Global Remicade (infliximab) Drug Revenue and Market Share by Type (2017-2022)
5.3 Global Remicade (infliximab) Drug Price by Type (2017-2022)
5.4 Global Remicade (infliximab) Drug Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Remicade (infliximab) Drug Sales, Revenue and Growth Rate of Brands Drugs (2017-2022)
5.4.2 Global Remicade (infliximab) Drug Sales, Revenue and Growth Rate of Generic Drugs (2017-2022)
6 Global Remicade (infliximab) Drug Market Analysis by Application
6.1 Global Remicade (infliximab) Drug Consumption and Market Share by Application (2017-2022)
6.2 Global Remicade (infliximab) Drug Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Remicade (infliximab) Drug Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Remicade (infliximab) Drug Consumption and Growth Rate of Crohn's Disease (2017-2022)
6.3.2 Global Remicade (infliximab) Drug Consumption and Growth Rate of Pediatric Crohn's Disease (2017-2022)
6.3.3 Global Remicade (infliximab) Drug Consumption and Growth Rate of Ulcerative Colitis (2017-2022)
6.3.4 Global Remicade (infliximab) Drug Consumption and Growth Rate of Pediatric Ulcerative Colitis (2017-2022)
6.3.5 Global Remicade (infliximab) Drug Consumption and Growth Rate of Other (2017-2022)
7 Global Remicade (infliximab) Drug Sales and Revenue Region Wise (2017-2022)
7.1 Global Remicade (infliximab) Drug Sales and Market Share, Region Wise (2017-2022)
7.2 Global Remicade (infliximab) Drug Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Remicade (infliximab) Drug Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Remicade (infliximab) Drug Market Forecast (2022-2029)
8.1 Global Remicade (infliximab) Drug Sales, Revenue Forecast (2022-2029)
8.1.1 Global Remicade (infliximab) Drug Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Remicade (infliximab) Drug Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Remicade (infliximab) Drug Price and Trend Forecast (2022-2029)
8.2 Global Remicade (infliximab) Drug Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Remicade (infliximab) Drug Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Remicade (infliximab) Drug Sales and Revenue Forecast (2022-2029)
8.2.3 China Remicade (infliximab) Drug Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Remicade (infliximab) Drug Sales and Revenue Forecast (2022-2029)
8.2.5 India Remicade (infliximab) Drug Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Remicade (infliximab) Drug Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Remicade (infliximab) Drug Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Remicade (infliximab) Drug Sales and Revenue Forecast (2022-2029)
8.3 Global Remicade (infliximab) Drug Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Remicade (infliximab) Drug Revenue and Growth Rate of Brands Drugs (2022-2029)
8.3.2 Global Remicade (infliximab) Drug Revenue and Growth Rate of Generic Drugs (2022-2029)
8.4 Global Remicade (infliximab) Drug Consumption Forecast by Application (2022-2029)
8.4.1 Global Remicade (infliximab) Drug Consumption Value and Growth Rate of Crohn's Disease (2022-2029)
8.4.2 Global Remicade (infliximab) Drug Consumption Value and Growth Rate of Pediatric Crohn's Disease (2022-2029)
8.4.3 Global Remicade (infliximab) Drug Consumption Value and Growth Rate of Ulcerative Colitis (2022-2029)
8.4.4 Global Remicade (infliximab) Drug Consumption Value and Growth Rate of Pediatric Ulcerative Colitis (2022-2029)
8.4.5 Global Remicade (infliximab) Drug Consumption Value and Growth Rate of Other (2022-2029)
8.5 Remicade (infliximab) Drug Market Forecast Under COVID-19
9 Industry Outlook
9.1 Remicade (infliximab) Drug Market Drivers Analysis
9.2 Remicade (infliximab) Drug Market Restraints and Challenges
9.3 Remicade (infliximab) Drug Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Remicade (infliximab) Drug Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Remicade (infliximab) Drug Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Remicade (infliximab) Drug Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
